TextBooks, Monographs, Chapters


 
1.   Gedda MR, Singh OP, Srivastavan OP, Sundar S. Therapeutic Leishmaniasis: RecentAdvancement and Developmentsin Nanomedicines. In Singh S, P. K. Maurya (eds.), Nanotechnology in Modern Animal Biotechnology, Springer Nature Singapore Pte Ltd. 2019 https://doi.org/10.1007/978-981-13-6004-6_6
 
 
2.   Sundar S, Chakravarty J. Leishmaniasis. In PG Text Book of Pediatrics (Eds. Gupta P, Menon PSN, Ramji S, Lodha R) 2nd Edition Jaypee Brothers New Delhi. pp 1478-84, 2018.
 
 
3.   Sundar S. Leishmaniasis. In Harrison’s Principles of Internal Medicine (Eds. Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Joscalzo J.) 19thEd. McGraw Hill Companies Inc. New York. pp 1387-94, 2015.20thEd. Pp1594-1601,2018
 
 
4.   Sundar S, Chakravarty J: Leishmaniasis – In Postgraduate Text Book of Paediatrics (editor Gupta P) pp1237-1243, 2015.
 
 
5.   Sundar S, Chakravarty J. Mechanism of Drug Resistance in Visceral Leishmaniasis. In Leishmania: Current Biology and Control (Eds. Adak S and Datta R). Caister Academic Press. Poole, UK. ISBN: 978-1-908230-52-2, 2015.
 
 
6.   Boelaert M, Sundar S. Leishmaniasis. In Manson’s Tropical Diseases (Eds. Farrar J, Hotez PJ, Junghanss T, Kang G, Lalloo D, White NJ). 23rd Ed. Elsevier Saunders pp 631-51, 2014.
 
 
7.   Manandhar KD, Yadav TP, Prajapati VK, Basukala O, Aganja RP, Dube A, Shrivastav ON, Sundar S. Nanonization Increases the Antileishmanial Efficacy of Amphotericin B: An Ex Vivo Approach. In R. Adhikari and S. Thapa (eds.), Infectious Diseases and Nanomedicine II, Advances in Experimental Medicine and Biology 808, Springer India, New Delhi. pp 77-91, 2014.
 
 
8.   Sundar S, Chakravarty J. Visceral Leishmaniasis. In Drug Resistance in Leishmania Parasites,(Ed. Ponte Sucre A) Springer-Verlag, Vienna. pp.183-98, 2013.
 
 
9.   Sundar S, Chakravarty J. Leishmaniasis: Challenges in the Control and Eradication. In Challenges in Infectious Diseases (Ed. Fong IW) Springer New York. pp 247-264, 2013.
 
 
10.               Sundar S. Leishmaniasis. In Harrison’s Principles of Internal Medicine (Eds. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Joscalzo J. 18th Ed. McGraw Hill Companies Inc. New York. pp 1709-16, 2012.
 
11.               Sundar S. Leishmaniasis. In API Textbook of Medicine (Eds. Munjal YP, Sharma SK, Agarwal AK, Gupta P, Kamath SA, Nadkar MY, Singhal RK, Sundar S, Varma S) 9th Edition. Association of Physicians of India, Mumbai. pp 1188-91, 2012.
 
12.               Sundar S, Arora R. Research on treatment of visceral leishmaniasis – Past, Present and Future. In Kala-azar – Emerging perspectives and prospects in South Asia. (Ed. HP Thakur) Mittal Publications; New Delhi pp 125 – 154, 2011.
 
 
13.               Sundar S, Agarwal D. A therapeutic strategy for treting visceral leishmaniasis in regions with drug resistance. In Kala-azar in South Asia (Eds Jha TK, Noiri E) Springer, London pp 35-46, 2011.
 
 
14.               Sundar S, Agarwal D. Antiretroviral. In Fundamentals of Global HIV Medicine (Eds. Temesgen Z, Amoroso A, Gilliam B, Goosby EP, Orenstein R ) IHL Press, College Park, USA. Ch 8: 77-83, 2010.
 
15.               Sundar S, Atilli VSS. Gastrointestinal complications of HIV Infection. In Fundamentals of Global HIV Medicine (Eds. Temesgen Z, Amoroso A, Gilliam B, Goosby EP, Orenstein R) IHL Press, College Park, USA. Ch 29: 257 66, 2010.
16.               Sundar S, Atilli VSS. Hepatobiliary complications of HIV Infection. In Fundamentals of Global HIV Medicine (Eds. Temesgen Z, Amoroso A, Gilliam B, Goosby EP, Orenstein R ) IHL Press, College Park, USA. Ch 30: 267-75, 2010.
17.               Cockrell DH, Sundar S, Angus B. Infectious disease .In Davidson’s Principles and Practice of Medicine (Eds. Colledge N, Walker B, Ralston S ) 21th Ed. Elsevier Publishers, Edinburgh, UK. Ch 13: 289-381, 2009.
 
18.               Sundar S. An Indian farmer with a high fever. In Davidson’s clinical cases. (Eds Strachan MWJ, Sharma SK, Hunter JAA) First Ed. Publishers, Edinburgh, UK. p. 56-9, 2008.
 
19.               Sundar S, Rai M. Parasitic Drug Resistance – Clinical :Leishmania. In Antimicrobial Drug Resistance (Eds – Mayers DL, Sobel JD, Ouellette M, Lerner s) 1st Ed Humana Press. Pp 1075-86, 2008.
 
20.               Sundar S. Leishmaniasis. In API Text Book of Medicine (Ed. S Shah). Association of Physicians of India, Mumbai. 8th Edition Chapter 62, pp. 130-133, 2008.
 
 
21.               M. Hide,1 B. Bucheton, S. Kamhawi, R. Bras-Goncalves, S. Sundar, J.-L. Lemesre, A.-L. Banuls. Understanding Human Leishmaniasis: The Need for an Integrated Approach. In Encyclopedia of Infectious Diseases: Modern Methodologies, (Ed. M.Tibayrenc). John Wiley & Sons, Inc, New York. Chapter 6, pp. 87-123, 2007.
 
22.               Sundar S, D. Agrawal and J. Chakravarty Leishmaniasis - Where Are We. In International ProceedingsTropical Medicine and International Health (5th Cong), (Ed. Boeree MJ) Medimond, Amsterdam. 135-42, 2007.
23.               Todd A, Lockwood D, Sundar S. Infectious disease. In Davidson’s Principles and Practice of Medicine (Eds. Boon N, Colledge N, Walker B, Hunter J) 20th Ed. Elsevier Publishers, Edinburgh, UK. P.283-376, 2006.
24.               Todd A, Sundar S, Lockwood. D Principles of Infectious disease .In Davidson’s Principles and Practice of Medicine (Eds. Boon N, Colledge N, Walker B, Hunter J) 20th Ed. Elsevier Publishers, Edinburgh, UK. P.129-158, 2006.
 
25.               Sundar S. Drug Trials. In Scientific Working Group Report on Leishmaniasis. TDR/WHO 71-73, 2004.
 
 
26.               Sundar S. Leishmaniasis. In Conn’s Current Therapy (Eds. Rakel RE, Bope ET). WB Saunders, Philadelphia, USA; pp90-93 2002.